Having trouble accessing articles? Reset your cache.

MediGene chronicles

MediGene chronicles

MediGene chroniclesSelected events tracked against MediGene’s weekly stock price (FSE:MDG). Y-axis = logarithmic scale A. 6/30/00 - Raises E125.4M ($117.4M) in an IPO. At that time, MDG was focused on developing therapeutics for cardiovascular and cancer indications. Lead programs included Etomoxir, about to start Phase II testing

Read the full 481 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers